Bharat Biotech's partner Ocugen seeks approval for Covaxin in Canada

The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults

Comments

Popular posts from this blog

Viral video involving woman cop sparks controversy, plaint filed

Congress groomed me not to sit at home: Shivakumar

Infosys lays off hundreds after failing internal assessments in Mysuru